BackgroundDuring the last decades, a renewed interest for negative symptoms (NS) was
brought about by the increased awareness that they interfere severely with real-life …

Abstract Background: Negative Symptoms (blunted affect, alogia, anhedonia, avolition and
asociality) are observed in schizophrenia but also in depressive disorders. Objective: To …

Background Intermittent theta burst stimulation (iTBS) over the dorsomedial prefrontal cortex
(DMPFC) has shown promise in open-label trials of depression. Methods In this randomized …

Negative symptoms, comprising the motivation and pleasure (MAP) factor and the
expressivity (EXP) factor, are key determinants of social functioning in schizophrenia (SCZ) …

Abstract Depressive symptoms in Schizophrenia Spectrum Disorders (SSDs) negatively
impact suicidality, prognosis, and quality of life. Despite this, efficacious treatments are …

Background. Agency, a sense of control over one's actions and outcomes, is crucial for
recovery from depressive symptoms. However, the mechanisms that enhance agency in …

Objective: Conceptual similarities between depressive and negative symptoms complicate
biomarker and intervention development. This study employed a data-driven approach to …

Objective The Community Assessment of Psychic Experiences has been widely translated
and commonly used as a measure for psychotic experiences and psychosis proneness in …

Introduction: Negative symptoms, neurocognitive deficits and functional impairment are
prevalent in individuals with major depressive disorder (MDD) and schizophrenia (SCZ) …

We characterized the neurocognitive profile of communed-based individuals and unaffected
siblings of patients with psychosis from Brazil reporting psychotic experiences (PEs). We …